Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Psoriasis: HELP
Bruce W. Kirkham
Based on 18 articles published since 2008
||||
Expertise Level
The expertise of Bruce W. Kirkham ranks in the
  • Top 0.53%
  • ... of 37,573 published authors worldwide on Psoriasis
  • ... from 2008 through 2019
  • ... based on contributions to 18 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
Expert badge
similar to this:
 
Aliases Kirkham, Bruce   ·   Kirkham, Bruce W   ·   Kirkham, B W   ·   Kirkham, B
Work Locations
Details
Most likely:    Guy's and St Thomas' NHS Trust      
2018
  • Institute of Infection, Immunity & Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, 120 University Place, Glasgow, G12 8TA, UK. · Swedish Medical Center and University of Washington, Seattle, WA, USA. · Friedrich-Alexander University of Erlangen-Nuremberg and Universitatsklinikum Erlangen, Erlangen, Germany. · Guy's & St Thomas' NHS Foundation Trust, London, UK. · Stanford University School of Medicine, Palo Alto, CA, USA. · RTI Health Solutions, Durham, NC, USA. · Novartis Pharma AG, Basel, Switzerland. · Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Pubmed 29880010
2017
  • Institute of Infection Immunity and Inflammation, University of Glasgow, Glasgow, UK. · Division of Rheumatology Clinical Research, Swedish Medical Centre and University of Washington, Seattle, WA. · Allergy/Immunology and Rheumatology Division, University of Rochester, Rochester, NY, USA. · Faculty of Medicine, Memorial University, St. John's, NL, Canada. · Department of Dermatology, New York Medical College, Valhalla, NY, USA. · Rheumatology Department, Guy's & St Thomas' NHS Foundation Trust, London, UK. · Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Novartis Pharma, Basel, Switzerland. · Pubmed 28968735
  • Department of Medicine, University of Queensland, Rheumatology Research Unit, Sunshine Coast, QLD, Australia. Electronic address: · Guy's and St Thomas' NHS Foundation Trust, London, UK. · Immuno-Rheumatology Center, St Luke's International University, St Luke's International Hospital, Tokyo, Japan. · Department of Medicine, Memorial University, St Clare's Mercy Hospital, St John's, NL, Canada. · Departement of Rheumatology, Lapeyronie Hospital, Montpellier Université, Montpelier, France. · Department of Rheumatology and Clinical Immunology, Charite University Medicine Berlin, Campus Mitte, Berlin, Germany. · Eli Lilly and Company, Indianapolis, IN, USA. · Department of Medicine, Stanford University, Palo Alto, CA, USA. · Pubmed 28551073
2016
  • Clinical Training Fellow. Centre for Molecular and Cellular Biology of Inflammation, Division of Immunology, Infection and Inflammatory Disease, King's College London, London. · Professor in Immunobiology and head of the Centre for Molecular and Cellular Biology of Inflammation, Division of Immunology, Infection and Inflammatory Disease, King's College London, London. · Consultant Rheumatologist in the Department of Rheumatology, Guy's & St Thomas' NHS Foundation Trust, London SE1 9RT. · Pubmed 27388392
2015
  • From the Swedish Medical Center and the University of Washington - both in Seattle (P.J.M.) · University of Glasgow, Glasgow (I.B.M.), and Guy's and St. Thomas' NHS Foundation Trust, London (B.K.) - both in the United Kingdom · University of California, San Diego, School of Medicine, San Diego (A.K.) · Memorial University, St. John's, NL, Canada (P.R.) · Leiden University Medical Center, Leiden (D.H.), and University of Amsterdam and Atrium Medical Center, Amsterdam (R.L.) - all in the Netherlands · University of Queensland, Brisbane, Australia (P.N.) · Novartis Pharmaceuticals, East Hanover, NJ (L.P., J.Y.) · and Novartis Pharma, Basel, Switzerland (H.B.R., S.M.). · Pubmed 26422723
  • Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK. Electronic address: · Swedish Medical Center and University of Washington, Seattle, WA, USA. · Guy's and St Thomas' NHS Foundation Trust, London, UK. · Department of Internal Medicine, Division of Rheumatology, Allergy and Immunology, San Diego School of Medicine, San Diego, CA, USA. · Allergy/Immunology and Rheumatology Division, University of Rochester, Rochester, NY, USA. · Memorial University, Newfoundland, NL, Canada. · Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands. · Amsterdam Rheumatology and Immunology Center, Amsterdam, and Atrium Medical Center, Heerlen, Netherlands. · NIHR Leeds Musculoskeletal Biomedical Research Unit and University of Leeds, Leeds, UK. · Department of Dermatology, Tufts Medical Center, Boston, MA, USA. · Novartis Pharma, Basel, Switzerland. · Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Novartis Healthcare, Hyderabad, India. · Pubmed 26135703
  • Guy's and St Thomas' NHS Foundation Trust, London, UK. · Katholieke Universiteit Leuven, Leuven, Belgium. · Quintiles, Collegeville, PA, USA. · Pfizer Inc, Collegeville, PA, USA. · Pfizer Europe, Rome, Italy. · Pubmed 25535650
2014
  • Department of Rheumatology, Guy's & St Thomas' NHS Foundation Trust, London, UK. · Pubmed 23819583
2017
  • From Clinical Investigation, The Rockefeller University, New York; Division of Allergy, Immunology, and Rheumatology, University of Rochester Medical Center, Rochester, New York, USA; Guy's and St. Thomas' UK National Health Service (NHS) Foundation Trust; King's College London, London, UK. · J.G. Krueger, MD, PhD, D. Martin Carter Professor in Clinical Investigation, The Rockefeller University; B. Kirkham, MD, Consultant Rheumatologist, Guy's and St. Thomas' NHS Foundation Trust, and Professor of Translational Rheumatology, King's College London; C.T. Ritchlin, MD, MPH, Professor of Medicine, Division of Allergy, Immunology, and Rheumatology, University of Rochester Medical Center. · From Clinical Investigation, The Rockefeller University, New York; Division of Allergy, Immunology, and Rheumatology, University of Rochester Medical Center, Rochester, New York, USA; Guy's and St. Thomas' UK National Health Service (NHS) Foundation Trust; King's College London, London, UK. · J.G. Krueger, MD, PhD, D. Martin Carter Professor in Clinical Investigation, The Rockefeller University; B. Kirkham, MD, Consultant Rheumatologist, Guy's and St. Thomas' NHS Foundation Trust, and Professor of Translational Rheumatology, King's College London; C.T. Ritchlin, MD, MPH, Professor of Medicine, Division of Allergy, Immunology, and Rheumatology, University of Rochester Medical Center. · Pubmed 28461524
2014
  • King's College London and Guy's and St. Thomas' Hospitals Foundation NHS Trust, London, UK. · Pubmed 24470327
  • Department of Rheumatology, Guy's & St Thomas' NHS Foundation Trust, , London, UK. · Pubmed 23994863
2013
  • St John's Institute of Dermatology, Division of Genetics and Molecular Medicine, King's College London and Guy's & St Thomas' NHS Foundation Trust, London, UK. · Pubmed 23278714
Probable:    University of Glasgow      
2015
  • From the Swedish Medical Center and the University of Washington - both in Seattle (P.J.M.) · University of Glasgow, Glasgow (I.B.M.), and Guy's and St. Thomas' NHS Foundation Trust, London (B.K.) - both in the United Kingdom · University of California, San Diego, School of Medicine, San Diego (A.K.) · Memorial University, St. John's, NL, Canada (P.R.) · Leiden University Medical Center, Leiden (D.H.), and University of Amsterdam and Atrium Medical Center, Amsterdam (R.L.) - all in the Netherlands · University of Queensland, Brisbane, Australia (P.N.) · Novartis Pharmaceuticals, East Hanover, NJ (L.P., J.Y.) · and Novartis Pharma, Basel, Switzerland (H.B.R., S.M.). · Pubmed 26422723
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 18 total) written by Bruce W. Kirkham about Psoriasis:

  • Secukinumab provides rapid and sustained pain relief in psoriatic arthritis over 2 years: results from the FUTURE 2 study. 2018
  • Secukinumab sustains improvement in signs and symptoms of psoriatic arthritis: 2 year results from the phase 3 FUTURE 2 study. 2017
  • Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial. 2017
  • Basic and Translational Science: A Report from the GRAPPA 2016 Annual Meeting. 2017
  • Psoriatic arthritis. 2016
  • Contribution of the IL-17 Pathway to Psoriasis and Psoriatic Arthritis. 2015
  • Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis. 2015
  • Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial. 2015
  • Early treatment of psoriatic arthritis is associated with improved patient-reported outcomes: findings from the etanercept PRESTA trial. 2015
  • Interleukin-17A: a unique pathway in immune-mediated diseases: psoriasis, psoriatic arthritis and rheumatoid arthritis. 2014
Show List of Full Article Records
Google Searches

Learn more about Bruce W. Kirkham using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Guy's and St Thomas' NHS Trust
University of Glasgow
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Guy's and St Thomas' NHS Trust
2018
  • Institute of Infection, Immunity & Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, 120 University Place, Glasgow, G12 8TA, UK. · Swedish Medical Center and University of Washington, Seattle, WA, USA. · Friedrich-Alexander University of Erlangen-Nuremberg and Universitatsklinikum Erlangen, Erlangen, Germany. · Guy's & St Thomas' NHS Foundation Trust, London, UK. · Stanford University School of Medicine, Palo Alto, CA, USA. · RTI Health Solutions, Durham, NC, USA. · Novartis Pharma AG, Basel, Switzerland. · Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Pubmed 29880010
2017
  • Institute of Infection Immunity and Inflammation, University of Glasgow, Glasgow, UK. · Division of Rheumatology Clinical Research, Swedish Medical Centre and University of Washington, Seattle, WA. · Allergy/Immunology and Rheumatology Division, University of Rochester, Rochester, NY, USA. · Faculty of Medicine, Memorial University, St. John's, NL, Canada. · Department of Dermatology, New York Medical College, Valhalla, NY, USA. · Rheumatology Department, Guy's & St Thomas' NHS Foundation Trust, London, UK. · Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Novartis Pharma, Basel, Switzerland. · Pubmed 28968735
  • Department of Medicine, University of Queensland, Rheumatology Research Unit, Sunshine Coast, QLD, Australia. Electronic address: · Guy's and St Thomas' NHS Foundation Trust, London, UK. · Immuno-Rheumatology Center, St Luke's International University, St Luke's International Hospital, Tokyo, Japan. · Department of Medicine, Memorial University, St Clare's Mercy Hospital, St John's, NL, Canada. · Departement of Rheumatology, Lapeyronie Hospital, Montpellier Université, Montpelier, France. · Department of Rheumatology and Clinical Immunology, Charite University Medicine Berlin, Campus Mitte, Berlin, Germany. · Eli Lilly and Company, Indianapolis, IN, USA. · Department of Medicine, Stanford University, Palo Alto, CA, USA. · Pubmed 28551073
2016
  • Clinical Training Fellow. Centre for Molecular and Cellular Biology of Inflammation, Division of Immunology, Infection and Inflammatory Disease, King's College London, London. · Professor in Immunobiology and head of the Centre for Molecular and Cellular Biology of Inflammation, Division of Immunology, Infection and Inflammatory Disease, King's College London, London. · Consultant Rheumatologist in the Department of Rheumatology, Guy's & St Thomas' NHS Foundation Trust, London SE1 9RT. · Pubmed 27388392
2015
  • From the Swedish Medical Center and the University of Washington - both in Seattle (P.J.M.) · University of Glasgow, Glasgow (I.B.M.), and Guy's and St. Thomas' NHS Foundation Trust, London (B.K.) - both in the United Kingdom · University of California, San Diego, School of Medicine, San Diego (A.K.) · Memorial University, St. John's, NL, Canada (P.R.) · Leiden University Medical Center, Leiden (D.H.), and University of Amsterdam and Atrium Medical Center, Amsterdam (R.L.) - all in the Netherlands · University of Queensland, Brisbane, Australia (P.N.) · Novartis Pharmaceuticals, East Hanover, NJ (L.P., J.Y.) · and Novartis Pharma, Basel, Switzerland (H.B.R., S.M.). · Pubmed 26422723
  • Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK. Electronic address: · Swedish Medical Center and University of Washington, Seattle, WA, USA. · Guy's and St Thomas' NHS Foundation Trust, London, UK. · Department of Internal Medicine, Division of Rheumatology, Allergy and Immunology, San Diego School of Medicine, San Diego, CA, USA. · Allergy/Immunology and Rheumatology Division, University of Rochester, Rochester, NY, USA. · Memorial University, Newfoundland, NL, Canada. · Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands. · Amsterdam Rheumatology and Immunology Center, Amsterdam, and Atrium Medical Center, Heerlen, Netherlands. · NIHR Leeds Musculoskeletal Biomedical Research Unit and University of Leeds, Leeds, UK. · Department of Dermatology, Tufts Medical Center, Boston, MA, USA. · Novartis Pharma, Basel, Switzerland. · Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Novartis Healthcare, Hyderabad, India. · Pubmed 26135703
  • Guy's and St Thomas' NHS Foundation Trust, London, UK. · Katholieke Universiteit Leuven, Leuven, Belgium. · Quintiles, Collegeville, PA, USA. · Pfizer Inc, Collegeville, PA, USA. · Pfizer Europe, Rome, Italy. · Pubmed 25535650
2014
  • Department of Rheumatology, Guy's & St Thomas' NHS Foundation Trust, London, UK. · Pubmed 23819583
2017
  • From Clinical Investigation, The Rockefeller University, New York; Division of Allergy, Immunology, and Rheumatology, University of Rochester Medical Center, Rochester, New York, USA; Guy's and St. Thomas' UK National Health Service (NHS) Foundation Trust; King's College London, London, UK. · J.G. Krueger, MD, PhD, D. Martin Carter Professor in Clinical Investigation, The Rockefeller University; B. Kirkham, MD, Consultant Rheumatologist, Guy's and St. Thomas' NHS Foundation Trust, and Professor of Translational Rheumatology, King's College London; C.T. Ritchlin, MD, MPH, Professor of Medicine, Division of Allergy, Immunology, and Rheumatology, University of Rochester Medical Center. · From Clinical Investigation, The Rockefeller University, New York; Division of Allergy, Immunology, and Rheumatology, University of Rochester Medical Center, Rochester, New York, USA; Guy's and St. Thomas' UK National Health Service (NHS) Foundation Trust; King's College London, London, UK. · J.G. Krueger, MD, PhD, D. Martin Carter Professor in Clinical Investigation, The Rockefeller University; B. Kirkham, MD, Consultant Rheumatologist, Guy's and St. Thomas' NHS Foundation Trust, and Professor of Translational Rheumatology, King's College London; C.T. Ritchlin, MD, MPH, Professor of Medicine, Division of Allergy, Immunology, and Rheumatology, University of Rochester Medical Center. · Pubmed 28461524
2014
  • King's College London and Guy's and St. Thomas' Hospitals Foundation NHS Trust, London, UK. · Pubmed 24470327
  • Department of Rheumatology, Guy's & St Thomas' NHS Foundation Trust, , London, UK. · Pubmed 23994863
2013
  • St John's Institute of Dermatology, Division of Genetics and Molecular Medicine, King's College London and Guy's & St Thomas' NHS Foundation Trust, London, UK. · Pubmed 23278714
University of Glasgow
2015
  • From the Swedish Medical Center and the University of Washington - both in Seattle (P.J.M.) · University of Glasgow, Glasgow (I.B.M.), and Guy's and St. Thomas' NHS Foundation Trust, London (B.K.) - both in the United Kingdom · University of California, San Diego, School of Medicine, San Diego (A.K.) · Memorial University, St. John's, NL, Canada (P.R.) · Leiden University Medical Center, Leiden (D.H.), and University of Amsterdam and Atrium Medical Center, Amsterdam (R.L.) - all in the Netherlands · University of Queensland, Brisbane, Australia (P.N.) · Novartis Pharmaceuticals, East Hanover, NJ (L.P., J.Y.) · and Novartis Pharma, Basel, Switzerland (H.B.R., S.M.). · Pubmed 26422723
7 Other Locations Show
Yearly article counts 013145200101
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.